[Estimation of the prevalence of low turn over renal osteodystrophy using biological markers in a peritoneal dialysis population].
Negri
A L
AL
Instituto de Investigaciones Metabólicas, Facultad de Medicina, Universidad del Salvador, Buenos Aires, Argentina.
Alvarez Quiroga
M
M
Bravo
M
M
Fradinger
E
E
Jacobo de Marino
A
A
Bogado
C E
CE
Zanchetta
J R
JR
D000328:Adult; D000368:Aged; D000469:Alkaline Phosphatase / Q000097:blood*; D000536:Aluminum Hydroxide / Q000627:therapeutic use; D015415:Biomarkers; D002117:Calcitriol / Q000008:administration & dosage / Q000627:therapeutic use; D002118:Calcium / Q000627:therapeutic use; D002614:Chelating Agents / Q000627:therapeutic use; D015913:Chelation Therapy; D012080:Chronic Kidney Disease-Mineral and Bone Disorder / Q000453:epidemiology* / Q000209:etiology; D003928:Diabetic Nephropathies / Q000150:complications / Q000628:therapy; D015314:Dialysis Solutions / Q000032:analysis; D005260:Female; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications / Q000601:surgery / Q000628:therapy; D016030:Kidney Transplantation; D008297:Male; D008875:Middle Aged; D010281:Parathyroid Hormone / Q000097:blood*; D016105:Parathyroidectomy; D010530:Peritoneal Dialysis / Q000009:adverse effects*; D010758:Phosphorus; D011183:Postoperative Complications / Q000628:therapy; D011237:Predictive Value of Tests; D015995:Prevalence; D012307:Risk Factors
D015415:Biomarkers; D002614:Chelating Agents; D015314:Dialysis Solutions; D010281:Parathyroid Hormone; D010758:Phosphorus; D000536:Aluminum Hydroxide; D000469:Alkaline Phosphatase; D002117:Calcitriol; D002118:Calcium